Editorial

HIVの免疫療法が前進

Nature Biotechnology 32, 5 doi: 10.1038/nbt.2907

The commencement of human trials of a gene therapy delivering HIV-neutralizing antibodies is a welcome addition to efforts to develop conventional vaccines against this scourge.

目次へ戻る

プライバシーマーク制度